Overview
This memorandum outlines the Quality Management System (QMS) employed by the Aria Diagnostics clinical laboratory team. While Laboratory quality standards are a regulatory requirement per our laboratory governing bodies (CAP & CLIA), it is also an ongoing management process that directly influences patient safety and clinical care decisions. Aria employs a systematic, data-led approach to quality assurance, utilizing a monthly dashboard of performance metrics that ensure analytical precision, accuracy, and processing efficiency.
Methodology of Monthly Reporting
Aria utilizes longitudinal quality metric tracking to identify trends. By analyzing data on a monthly aggregate basis, we shift from reactive troubleshooting to overall system performance and health. This approach focuses on three core phases within our laboratory testing workflow:
1. Pre-Analytical Integrity (Patient Demographics and Sample Validity)
Pre-analytical errors are issues occurring before the sample reaches the testing platform and account for the vast majority of laboratory variances. We track multiple factors related to sample acceptance/rejection criteria to safeguard sample processing, resulting, and benefits coverage integrity. Below are a few of these quality categories:
- Sample Rejection Rate Analysis: We monitor aggregate trends in rejected specimens (e.g., hemolysis, temperature variance) to identify root causes in collection or transport, providing actionable feedback to clinical sites to reduce the need for patient recall.
- Administrative Hold Resolution: We track the number and duration of samples held for administrative reasons (such as missing insurance or ICD-10 codes) to streamline the intake process and prevent downstream billing complications.
- Sample Accessioning Accuracy: We monitor specimen labeling accuracy, barcode scanning success rates, and chain-of-custody documentation to ensure proper patient-specimen matching and traceability throughout the testing lifecycle, preventing potentially catastrophic specimen mix-ups.
2. Analytical Precision (Testing Reliability)
The reliability of a result is defined by the integrity of the testing platform. Our monthly analytical reports include:
- Instrument Health & Maintenance: Uptime logs and preventative maintenance schedules help ensure all platforms operate within strict manufacturer specifications, minimizing the risk of downtime delaying patient results.
- Assay Performance & Re-run Rates: Frequency of required re-testing is monitored through low and stable re-run rates. This metric validates the technical consistency of the assay and ensures that the final reported values are analytically defensible.
- Calibration & Quality Control (QC) Verification: We perform high precision daily QC and instrument calibrations, analyzing data against statistical control limits and limits of analyte detection (LOD) to guarantee that the instrument was performing accurately at the exact moment the patient’s sample was analyzed.
3. Post-Analytical Efficiency (Turnaround Times)
Timely reporting is critical for urgent care decisions related to medication monitoring and management protocols. We measure Turnaround Time (TAT) through multiple perspectives:
- Total Clinical Turnaround (Collection-to-Finalization): the total time from patient appointment to final result delivery. This data allows us to audit facility shipping routines, courier routes, and transport logistics for transport efficiency.
- Analysis Processing Speed (Laboratory Receipt-to-Finalization TAT): we isolate the time from laboratory accessioning to result release to ensure our technical teams are meeting internal benchmarks for processing speed and batching work effectively.
- Bottleneck Decoupling: an analysis of the total clinical turn-around time vs analysis processing speed is done to pinpoint systemic delays, whether in transport or lab workflow to avoid disruptions to clinical operational flow.
Why Is This Important?
The primary function of these quality management systems and associated metrics is to support both the clinician and patient. A consistent, reliable testing workflow helps facilitate patient scheduling, swift and appropriate standard of care decisions, and necessary testing adjustments. Furthermore, this level of tracking and workflow discipline helps protect our workplace standard of ongoing audit-readiness of the laboratory and the individuals at Aria who support this critical clinical work.